
    
      Patients will be randomized between Paromomycin cream applied topically once daily for 20
      days (group 1--40 patients), pentamidine administered intralesionally at 120 ug/mm2 on days
      1, 3, 5 (group 2-20 patients), and cream vehicle applied topically once daily for 20 days
      (group 3-20 patients).

      After treatment, all patients will be followed for 1, 3, and 6 months.
    
  